In addition, we also determined the correlation of TM expression with the relapse-free survival rate and found that ER+ breast cancer patients with higher TM (n = 1316) had a better relapse-free survival rate compared to the lower TM in ER+ breast cancer patients (n = 1317) (Figure 1B). This evidence concerns the gene ESR1 and breast carcinoma.